Neurocrine Bioscienc(NBIX-Q)NASDAQ
Today's Change
Real-Time Last Update
Pre Market Change
Pre Market Last Update
Volume
Current Target Price
High Target Price
Mean Target Price
Low Target Price
Median Target Price
Earnings Estimates
| Current Qtr12/2024 | Next Qtr03/2025 | Fiscal Yr12/2024 | Fiscal Yr12/2025 | |
|---|---|---|---|---|
| Average Estimate | 1.58 | 1.27 | 3.93 | 6.37 |
| Number of Estimates | 10 | 4 | 10 | 11 |
| High Estimate | 1.92 | 1.49 | 4.20 | 7.47 |
| Low Estimate | 1.33 | 1.06 | 3.62 | 5.32 |
| Prior Year | 1.44 | 0.42 | 2.47 | 3.93 |
| Growth Rate Est. (year over year) | +9.72% | +202.38% | +59.11% | +62.09% |
Earnings History - Surprises*
| Qtr Ending09/2024 | Qtr Ending06/2024 | Qtr Ending03/2024 | Qtr Ending12/2023 | |
|---|---|---|---|---|
| Reported | $1.24 | $0.63 | $0.42 | $1.44 |
| Estimate | $1.47 | $1.15 | $1.04 | $1.13 |
| Difference | -0.23 | -0.52 | -0.62 | +0.31 |
| Surprise | -15.65% | -45.22% | -59.62% | +27.43% |
* Earnings are based on GAAP income from continuing operations.
Average Analyst Ratings
Rating
Strong Buy
Moderate Buy
Hold
Moderate Sell
Strong Sell
# of Analysts
4.54
3 Mths Ago26
4.62
2 Mths Ago26
4.62
1 Mth Ago26
4.59
Current27
Ratings Values:
Strong Buy5
Moderate Buy4
Hold3
Moderate Sell2
Strong Sell1
Ratings Breakdown
| 3 Mths Ago | 2 Mths Ago | 1 Mth Ago | Current | |
|---|---|---|---|---|
| # of Analysts: | 26 | 26 | 26 | 27 |
20 | 21 | 21 | 21 1 | |
| Holds | 6 | 5 | 5 | 5 |
Key:
Strong Buy
Moderate Buy
Hold
Moderate Sell
Strong Sell